MRVI - Company ID 0001823239
The table below shows MARAVAI LIFESCIENCES HOLDINGS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $8.66M | -$9.39M | -$8.47M | $85.07M | $162.30M | $38.33M |
| Capital expenditure | $4.44M | $4.50M | $5.67M | $7.87M | $2.75M | $3.33M |
| Investing cash flow | -$4.44M | -$23.13M | -$4.24M | -$69.73M | -$241.58M | -$2.78M |
| Dividends paid | - | - | - | - |
MARAVAI LIFESCIENCES HOLDINGS, INC. reported operating cash flow of -$57.57M for fiscal year 2025. That is down 871.2% from $7.46M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from $24.11M (FY 2019) to -$57.57M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$55.23M | -$4.90M | -$560.00K | -$19.21M | -$40.52M | -$24.06M |